Basic Information
ONGLYZA
54868-6309
Regulatory Information
54868-6309
NDA022350
C73594
January 9, 2012
USA
These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets Initial U.S. Approval: 2009
HUMAN PRESCRIPTION DRUG LABEL
3
Company Information
194123980
Active Ingredients
lactose monohydrate
Code: EWQ57Q8I5X
Class Code: IACT
cellulose, microcrystalline
Code: OP1R32D61U
Class Code: IACT
croscarmellose sodium
Code: M28OL1HH48
Class Code: IACT
magnesium stearate
Code: 70097M6I30
Class Code: IACT
Active Moieties
saxagliptin
Code: 9GB927LAJW